Curaleaf Holdings (CURLF) Cash & Equivalents (2019 - 2026)

Curaleaf Holdings has reported Cash & Equivalents for 8 years, with the latest figure at $94.6 million in Q2 2026.

• On a quarterly basis, Cash & Equivalents rose 7.8% year-over-year to $94.6 million in Q2 2026; TTM through Jun 2026 was $94.6 million, a 7.8% increase from a year earlier, with the FY2025 full-year figure at $89.2 million, down 16.8% from the prior year.
• Cash & Equivalents was $94.6 million for Q2 2026 at Curaleaf Holdings, down from $106.1 million in the prior quarter.
• The five-year high for Cash & Equivalents was $242.6 million in Q1 2022, with the low at $85.0 million in Q2 2023.
• Average Cash & Equivalents over 5 years is $122.3 million, with a median of $106.7 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2025: Cash & Equivalents slumped 54.56% in 2023, then rose 17.07% in 2025.
• Over 5 years, Cash & Equivalents stood at $163.2 million in 2022, then sank by 43.73% to $91.8 million in 2023, then gained by 16.78% to $107.2 million in 2024, then decreased by 16.8% to $89.2 million in 2025, then gained by 6.02% to $94.6 million in 2026.
• The last three Cash & Equivalents figures came in at $94.6 million (Q2 2026), $106.1 million (Q1 2026), and $89.2 million (Q4 2025), per Business Quant data.